Abstract
Using melanoma and HCC tumor models in mice, this study demonstrates the potential of ABX196, alone and in combination with anti-PD-1 antibody, as a novel strategy to overcome the immunosuppressive microenvironment and to produce antitumor activity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have